TrialFind
Saved trials
Back to results
Terminated
Phase 3
Adjunctive Lisdexamfetamine (LDX) in Bipolar Depression
NCT01131559
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Primary location
Lindner Center of HOPE
Mason, Ohio, United States
View on ClinicalTrials.gov
Official details
Adjunctive Lisdexamfetamine (LDX) in Bipolar Depression — TrialFind